What you need to know about the cost of cancer treatments and cancer plans

43 per cent of Singaporeans are not prepared for a cancer diagnosis.** Are you one of them? Find out about the cancer plans available to ease the cost of cancer treatments and get immediate coverage online for the number 1 critical illness in Singapore with iFAST Digital Term and Cancer360 rider. Updated on 16 Jan 2025.

iFAST Insurance Team
iFAST Insurance Team17 Jan 2024 5563 Views

Did you know that almost half of Singaporeans who have not had cancer before think that they are not financially prepared for a cancer diagnosis?1 With 1 in 4 people at risk of developing cancer in their lifetime2, it is essential that we educate and prepare ourselves for any unexpected situations. In this article, we shed light on the estimated cost of cancer treatments in Singapore, and share how having adequate insurance coverage can help us to better prepare for the unexpected.


Cost of cancer treatments in Singapore

As you can see from the table below, the average cost of procedure for some of the common cancers ranges from $20,000 to $60,000.

Hospital bills and fees shown in the table above were retrieved from Ministry of Health's website on 16 January 2024.


Do I really need cancer insurance?

A cancer diagnosis can be a life changing event with an astronomical amount needed for both cancer treatments and other daily expenses. While MediShield Life and Integrated Shield plans can provide coverage for specified cancer treatments, these hospital bills are not the only costs that you may need. In addition to medical bills, you may also incur other expenses such as hiring a caregiver for your dependents, or to care for your own daily needs.

According to a study done by the Life Insurance Association Singapore (LIA), the average recovery period after a Critical Illness diagnosis is 4.6 years.3 This means that an individual is likely to require income replacement for approximately 4.6 years. Having an insurance plan with cancer coverage will then allow you to receive a lump sum pay-out that you may use to cover your expenses during this recovery period.


How much can I expect to pay for cancer coverage?

If you are worried about the potential costs arising from a cancer diagnosis, you may wish to consider getting a plan that offers cancer coverage. We show some of the available options in the table below. There are different features in the plans, including whether the policy term is fixed or renewable for a period of time, or till a specific age, and different clients may have different considerations on which features are more important to meet their needs.

Essential Cancer Care
Complete cancer care (Care 100)
TM #GoTotalProtect cancer
Insured by
Etiqa
Income
Tokio Marine

Policy Term
5 or 10 year renewable plan, or fixed term to specific age

10 years fixed term

Fixed term to specific age

Cancer coverage given
Staggered pay-outs. Accelerates 50% sum assured for early or intermediate stage cancer.
Pays out 100% of sum assured for all stage major cancer.
Pays out 100% of sum assured for early and intermediate stage cancer, and up to 150% of sum assured for advanced stage cancer.

Online purchase available?
No
No
No
Sample premiums
Cancer coverage amount
$200,000
$200,000
$200,000
Death coverage
$3,000
$5,000
$10,000
Policy Term
10 year renewable term
10 year fixed term
10 year fixed term
Annual premiums*
$666
$879.10
$752

*Profile: Female, non-smoker, birthdate: 01/01/1995. Premiums are accurate as of 16 January 2025.

This comparison does not include information on all similar products. iFAST does not guarantee that all aspects of the products have been illustrated. You may wish to conduct your own comparison for products that are listed in www.comparefirst.sg


For alternative cancer coverage: iFAST Digital Term

Alternatively, if you would like to get coverage for cancer but do not want to undergo medical underwriting, you may consider a generalised insurance strategy using iFAST Digital Term.

Did you know that iFAST Digital Term also offers cancer coverage via its Cancer360 rider? Offering coverage for all stages of cancer, Cancer360 rider provides a lump sum pay-out upon diagnosis of early-stage cancer. Moreover, this cancer benefit pays on an additional basis. This means that claims paid out for your Cancer360 rider will not reduce the sum assured of your core iFAST Digital Term plan. Cancer coverage offered for Cancer360 starts from $50,000.

iFAST Digital Term^ + Cancer360 rider
Insured by
Raffles Health Insurance
Policy Term
Yearly renewable

Cancer coverage given
Pays out 100% of sum assured upon diagnosis of all stage cancer

Online purchase available?
Yes, online application available. Just answer 3 questions.
Sample premiums for Profile: Female, non-smoker, birthdate 01/01/1995
Coverage given
$200,000 cancer with $50,000 death coverage
Annual premiums^
$169.50

^This product is a yearly renewable group term life policy, renewal premium is based on life assured’s attained age. Premium will increase with age.


Huat?! Get $8 Angbao* with every iFAST Digital Term purchase🤑

From now till 16 February 2025, get a $8 Angbao* with every iFAST Digital Term plan purchased! Simply head over to iFAST Digital Term webpage to get a free quote. Remember to key in promo code “HUAT” at policy purchase page to be eligible for this promotion. Your coverage will be issued immediately and you will receive your Reward in your FSM Cash Account within 3 weeks after the end of the campaign period.

*Terms and Conditions apply.



Save more when you insure with FSMOne


Get covered with iFAST Digital Term and enjoy up to 45% commission rebates




For traditional term insurance alternatives where online purchase is not available,

At FSMOne, we also work with various insurance partners to provide offline term insurance solutions. Speak to us at ins.sg@ifastfinancial.com if you would like to find out more. Alternatively, you may also leave an enquiry here for a free customised quotation.


Click here for a complimentary insurance review with our team





Available Products on FSMOne Insurance

Term Life, Whole Life, Critical Illness, Annuity, Health, Endowment, General Insurance (Personal and Commercial)


from AIG, Allianz, Cigna, Chubb, Etiqa Insurance, FWD Insurance, Great Eastern, Henner, Income, Manulife, MSIG, Raffles Health Insurance, Singlife, Sompo, Tokio Marine, and QBE.


*Please check with our team if the product you want is available on FSMOne Insurance





1Source: https://www.todayonline.com/singapore/nearly-half-singaporeans-feel-they-are-not-financially-prepared-handle-cancer-diagnosis-study-2342491?cid=telegram_tg-single_social-free_26012019_today

2Source: https://www.singaporecancersociety.org.sg/learn-about-cancer/cancer-basics/common-types-of-cancer-in-singapore.html

3Source: https://www.lia.org.sg/media/3974/lia-pgs-2022-report_final_8-sep-2023.pdf

**Source: https://www.todayonline.com/singapore/nearly-half-singaporeans-feel-they-are-not-financially-prepared-handle-cancer-diagnosis-study-2342491?cid=telegram_tg-single_social-free_26012019_today



Disclaimer:

All materials and content found in this article are strictly for information purposes only and should not be considered as an offer or solicitation to transact in any product. This article is not a contract of insurance.

iFAST Digital Term and its riders are issued and underwritten by Raffles Health Insurance Pte Ltd and distributed by iFAST Financial Pte Ltd (“iFAST”). You are advised to read the precise terms, conditions and exclusions specified in the policy contract.

You are advised to read the key product documents, including (but not limited to) the product summary, before deciding whether the product is suitable for you. You should consider carefully if the products you are purchasing are suitable for your financial objectives, experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of a product, please seek advice from a financial adviser before making a decision to purchase the product.

As buying a life insurance policy is a long term-commitment, an early termination of the policy usually involves high costs and the surrender value, if any, that is payable to you may be zero or less than the total premiums paid.

While iFAST and/or any of its third-party providers has/have tried to provide accurate and timely information, there may be inadvertent omissions, inaccuracies, and typographical errors. Opinions expressed herein are subjected to change without notice.

More information on iFAST Digital Term can be found here

This advertisement has not been reviewed by the Monetary Authority of Singapore.

All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.